Place of Prasugrel, P2Y12 Receptor Antagonist, in an Early Invasive Treatment of Patients with Acute Coronary Syndrome (according to the Results of Multicenter Randomized Controlled Trial ISAR-REACT 5)S. N. Tereshchenko,M. G. Glezer,S. A. Abugov,O. V. Averkov, S. I. Antipov,A. S. Galyavich,M. Yu. Gilyarov,D. V. Duplyakov,A. A. Efremushkina,D. A. Zateyshchikov,V. V. Ivanenko,E. D. Kosmacheva,O. V. Krestyaninov,Yu. M. Lopatin,E. P. Panchenko,V. V. Ryabov, E. V. Samokhvalov,I. I. Staroverov,S. A. Ustyugov,A. V. Khripun,S. V. Shalaev,R. M. Shakhnovich,I. S. Yavelov,A. N. Yakovlev,S. S. YakushinRossijskij kardiologičeskij žurnal（2019）引用 2|浏览9暂无评分关键词acute coronary syndrome,prasugrel,p2y12 receptor blockerAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
